EU approves Gilead's HIV drug combo

02/24/2005 | iWon

Gilead Sciences reports it received European Commission approval to market its HIV drug Truvada in the European Union. Truvada combines two HIV drugs, Emtriva and Viread, in one pill, which can be taken once a day along with other antiretroviral medicines.

View Full Article in:

iWon

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY